Found: 226
Select item for more details and to access through your institution.
Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12973-0
- By:
- Publication type:
- Article
Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0942-x
- By:
- Publication type:
- Article
Correction: Data Sharing Goals for Nonprofit Funders of Clinical Trials.
- Published in:
- Journal of Participatory Medicine, 2021, v. 13, n. 2, p. N.PAG, doi. 10.2196/31371
- By:
- Publication type:
- Article
Data Sharing Goals for Nonprofit Funders of Clinical Trials.
- Published in:
- Journal of Participatory Medicine, 2021, v. 13, n. 1, p. N.PAG, doi. 10.2196/23011
- By:
- Publication type:
- Article
Thrombolytic therapy in older acute ischemic stroke patients with gastrointestinal malignancy or recent bleeding.
- Published in:
- European Stroke Journal, 2020, v. 5, n. 1, p. 47, doi. 10.1177/2396987319871784
- By:
- Publication type:
- Article
Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 10, p. 1, doi. 10.1111/dme.14552
- By:
- Publication type:
- Article
Utilization and Outcomes of Extracorporeal Membrane Oxygenation Following Traumatic Brain Injury in the United States.
- Published in:
- Journal of Intensive Care Medicine, 2023, v. 38, n. 5, p. 440, doi. 10.1177/08850666221139223
- By:
- Publication type:
- Article
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1714, doi. 10.1111/dom.15479
- By:
- Publication type:
- Article
Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR‐TIMI 53 cardiovascular outcomes trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 5, p. 1101, doi. 10.1111/dom.14313
- By:
- Publication type:
- Article
Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 798, doi. 10.1111/dom.13958
- By:
- Publication type:
- Article
Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis.
- Published in:
- European Heart Journal, 2023, v. 44, n. 48, p. 5077, doi. 10.1093/eurheartj/ehad586
- By:
- Publication type:
- Article
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2930, doi. 10.1093/eurheartj/ehad283
- By:
- Publication type:
- Article
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2982, doi. 10.1093/eurheartj/ehad344
- By:
- Publication type:
- Article
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2170, doi. 10.1093/eurheartj/ehad276
- By:
- Publication type:
- Article
Dapagliflozin for heart failure according to body mass index: the DELIVER trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4406, doi. 10.1093/eurheartj/ehac481
- By:
- Publication type:
- Article
Patient partnership in cardiovascular clinical trials.
- Published in:
- European Heart Journal, 2022, v. 43, n. 14, p. 1432, doi. 10.1093/eurheartj/ehab835
- By:
- Publication type:
- Article
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
- Published in:
- European Heart Journal, 2020, v. 41, n. 22, p. 2109, doi. 10.1093/eurheartj/ehaa461
- By:
- Publication type:
- Article
Splanchnic nerve block for decompensated chronic heart failure: splanchnic-HF.
- Published in:
- European Heart Journal, 2018, v. 39, n. 48, p. 4255, doi. 10.1093/eurheartj/ehy682
- By:
- Publication type:
- Article
Clinical trial site readiness for decentralized trials -- fitting trials into today's world.
- Published in:
- Journal of Clinical & Translational Science, 2024, v. 8, n. 1, p. 1, doi. 10.1017/cts.2024.17
- By:
- Publication type:
- Article
Engaging patients throughout the health system: A landscape analysis of cold-call policies and recommendations for future policy change.
- Published in:
- Journal of Clinical & Translational Science, 2018, v. 2, n. 6, p. 384, doi. 10.1017/cts.2019.1
- By:
- Publication type:
- Article
Age Differences in the Use of Implantable Cardioverter-Defibrillators Among Older Patients Hospitalized with Heart Failure.
- Published in:
- Journal of Cardiovascular Electrophysiology, 2013, v. 24, n. 6, p. 664, doi. 10.1111/jce.12100
- By:
- Publication type:
- Article
The Future of Clinical Trials: Artificial to Augmented to Applied Intelligence.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 21, p. 2061, doi. 10.1001/jama.2023.23822
- By:
- Publication type:
- Article
Proactive Algorithm Monitoring to Ensure Health Equity.
- Published in:
- 2023
- By:
- Publication type:
- Opinion
Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study.
- Published in:
- JAMA Neurology, 2019, v. 76, n. 10, p. 1192, doi. 10.1001/jamaneurol.2019.2099
- By:
- Publication type:
- Article
Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
- Published in:
- JAMA Neurology, 2016, v. 73, n. 1, p. 50, doi. 10.1001/jamaneurol.2015.3106
- By:
- Publication type:
- Article
Relationship Between Early Physician Follow-up and 30-Day Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 303, n. 17, p. 1716, doi. 10.1001/jama.2010.533
- By:
- Publication type:
- Article
Aldosterone Antagonists in Patients With Heart Failure.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Use of Aldosterone Antagonists in Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2009, v. 302, n. 15, p. 1658, doi. 10.1001/jama.2009.1493
- By:
- Publication type:
- Article
BNP-Guided Heart Failure Therapy in Older Patients.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Outcomes of Medicare Beneficiaries With Ventricular Assist Devices.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare Beneficiaries.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 300, n. 20, p. 2398, doi. 10.1001/jama.2008.716
- By:
- Publication type:
- Article
Association of Patient Case-Mix Adjustment, Hospital Process Performance Rankings, and Eligibility for Financial Incentives.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 300, n. 16, p. 1897, doi. 10.1001/jama.300.16.1897
- By:
- Publication type:
- Article
Implantable Cardioverter-Defibrillators, Heart Failure, and Patient Characteristics.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Sex and Racial Differences in the Use of Implantable Cardioverter-Defibrillators Among Patients Hospitalized With Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 13, p. 1525, doi. 10.1001/jama.298.13.1525
- By:
- Publication type:
- Article
Sex Differences in the Use of Implantable Cardioverter-Defibrillators for Primary and Secondary Prevention of Sudden Cardiac Death.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 13, p. 1517, doi. 10.1001/jama.298.13.1517
- By:
- Publication type:
- Article
Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008- March 2018.
- Published in:
- PLoS ONE, 2019, v. 14, n. 12, p. 1, doi. 10.1371/journal.pone.0223515
- By:
- Publication type:
- Article
Assessing heterogeneity of treatment effect analyses in health-related cluster randomized trials: A systematic review.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0219894
- By:
- Publication type:
- Article
Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 6, p. 445, doi. 10.1002/pst.1823
- By:
- Publication type:
- Article
Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The impact of COVID-19 on pragmatic clinical trials: lessons learned from the NIH Health Care Systems Research Collaboratory.
- Published in:
- Trials, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13063-022-06385-8
- By:
- Publication type:
- Article
Generating evidence for therapeutic effects: the need for well-conducted randomized trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose‐lowering therapy: A pre‐specified analysis of the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1539, doi. 10.1002/ejhf.3269
- By:
- Publication type:
- Article
Dapagliflozin and quality of life measured using the EuroQol 5‐dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1524, doi. 10.1002/ejhf.3263
- By:
- Publication type:
- Article
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant‐level pooled analysis of DAPA‐HF and DELIVER.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 912, doi. 10.1002/ejhf.3184
- By:
- Publication type:
- Article
Iron replacement therapy in heart failure: Contextualizing the results of the HEART‐FID trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 3, p. 537, doi. 10.1002/ejhf.3193
- By:
- Publication type:
- Article
Impact of COVID‐19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2177, doi. 10.1002/ejhf.3043
- By:
- Publication type:
- Article
Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1663, doi. 10.1002/ejhf.3001
- By:
- Publication type:
- Article
Baseline characteristics of patients enrolled in the EMPACT‐MI trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1708, doi. 10.1002/ejhf.2990
- By:
- Publication type:
- Article
Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1364, doi. 10.1002/ejhf.2912
- By:
- Publication type:
- Article
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 1170, doi. 10.1002/ejhf.2915
- By:
- Publication type:
- Article